Enter assignee name

Forward Citations = 2

Loading Chart...

8 inventors (with patents filed for the assignee):

John Somberg (3 out of 4 patents)

Somberg John (2 out of 2 patents)

Thomas Gerner Jacobsen (2 out of 2 patents)

4. Atul Patil (2 out of 2 patents)

5. Paul Hafey (1 out of 4 patents)

6. L Diane Bruce (1 out of 1 patent)

7. Mohammad Alkhalili (1 out of 1 patent)

8. Mary Beth G Erstad (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 12521357 - Intravenous dofetilide to convert atrial fibrillation/flutter (2026-01-13),

2. 12508315 - Use of vitamin E TPGS as a taste masking agent for bitter drugs (2025-12-30),

3. 12357644 - Acetyl salicylic acid composition for intravenous administration, its storage, production and use (2025-07-15),

4. 12343320 - Intraveneous dofetilide to reduce the risk of developing AF/AFL post coronary bypass surgery (2025-07-01),

5. 12121520 - Metolazone emulsion formulation (2024-10-22),

6. 11957648 - Method of initiating or escalating dofetilide dose and formulations therefor (2024-04-16),

7. 11666532 - Tranexamic acid oral solution (2023-06-06),

8. 11413241 - Method for preparing a composition with a low dissolved oxygen content, comprising acetaminophen, and optionally one or more NSAIDs, and a composition obtained thereof (2022-08-16),

9. 11389451 - Metolazone emulsion formulation (2022-07-19),

Hyloris Developments Sa is a specialty biopharmaceutical company focused on developing and commercializing innovative products for niche markets. The company utilizes its proprietary technology platform to reformulate existing drugs to improve their efficacy, safety, and patient compliance. Hyloris is dedicated to bringing novel treatment options to patients with unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

9 Patents

#4 in Liège

#279 in Belgium

Liège, Belgium

Hyloris Developments Sa